2018 annual financial data

Bolt Biotherapeutics, Inc. 2018 Operating margin

Bolt Biotherapeutics, Inc. 2018 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -11,629,000 USD and net income was -11,589,000 USD.
Operating cash flow was -9,872,000 USD.

Get free Bolt Biotherapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-11,629,000 USD
Net income
-11,589,000 USD
Operating cash flow
-9,872,000 USD